Device type · SFC
Neurologic Disease Risk Assessment Molecular Test
Last checked: Nov 20, 2026Source: openFDAMethods & limitations
Product code
SFC
Immunology
Device class
Class II
FDA decisions since 2015
1
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Neurologic Disease Risk Assessment Molecular Test
- Product code
- SFC
- Device class
- Class II
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5850
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for SFC
Latest FDA decisions
- APO-Easy Genotyping kitNew device typeDe Novo
DEN240032 · Decided Jun 12, 2025 · 356 days after receipt
Device type: Neurologic Disease Risk Assessment Molecular Test (SFC) · Laboratory Medicine & Pathology
Reports received
0
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recalls for this product code in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.